Neffy (epinephrine nasal spray): key features, administration, and delivery mechanism
use cautiously in patients with gout [16] [25] Myopathy risk : When combined with statins, increased risk of muscle symptoms requires monitoring Glucose effects : Dose-dependent increases in blood glucose and A1c Monitoring recommendations: Glucose monitoring is paramount, particularly during the first few weeks after initiating or adjusting either medication
GLP-1 medications are generally indicated for adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related health condition (such as type 2 diabetes, hypertension, or high cholesterol)
They also tend to experience more pronounced nausea with GLP-1 medications
However, differences in sociodemographic profile and comorbidities were present, such as higher incomes and educational level of GLP-1 RAs users compared with SGLT-2 inhibitor users and DPP-4 inhibitor users suggesting selection bias in prescription
